ARTICLE | Company News
Amarillo, Cyto Biotech Co. Ltd. deal
March 9, 2009 7:00 AM UTC
Cyto Biotech received an exclusive, worldwide license, excluding China and Taiwan, to develop and commercialize Amarillo's low dose oral interferon for all indications. Cyto Biotech has non-exclusive ...